Literature DB >> 18332244

Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease.

Scott A Small1.   

Abstract

During the tail end of the 20th century, a "golden period" in Alzheimer disease (AD) research, many of the pathogenic molecules of the autosomal dominant form of the disease were isolated. These molecular defects, however, do not exist in "sporadic" late-onset AD, the form of the disease that accounts for more than 95% of all cases. Pinpointing the pathogenic molecules of late-onset AD has, therefore, become an urgent goal, both for understanding disease mechanisms and for opening up novel therapeutic avenues. The retromer sorting pathway transports cargo along the endosome-trans-Golgi network, and retromer defects were first implicated in late-onset AD by a study that combined brain imaging with microarray. A range of studies have confirmed that defects in this pathway can play a pathogenic role in the disease. Herein, these findings will be reviewed, the details of the retromer sorting pathway will be discussed, and a biological model that can account for the disease's regional selectivity will be elaborated.

Entities:  

Mesh:

Year:  2008        PMID: 18332244      PMCID: PMC2726781          DOI: 10.1001/archneurol.2007.64

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

1.  The genes for the human VPS10 domain-containing receptors are large and contain many small exons.

Authors:  W Hampe; M Rezgaoui; I Hermans-Borgmeyer; H C Schaller
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

Review 2.  The ins and outs of Wingless signaling.

Authors:  Elaine S Seto; Hugo J Bellen
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

Review 3.  Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain.

Authors:  Aimee Pierce; Scott A Small
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Entorhinal cortex modules of the human brain.

Authors:  A Solodkin; G W Van Hoesen
Journal:  J Comp Neurol       Date:  1996-02-19       Impact factor: 3.215

5.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

6.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Beta-catenin is critical for dendritic morphogenesis.

Authors:  Xiang Yu; Robert C Malenka
Journal:  Nat Neurosci       Date:  2003-10-05       Impact factor: 24.884

9.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

10.  Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor.

Authors:  Cecilia N Arighi; Lisa M Hartnell; Ruben C Aguilar; Carol R Haft; Juan S Bonifacino
Journal:  J Cell Biol       Date:  2004-04       Impact factor: 10.539

View more
  34 in total

Review 1.  Cargo trafficking in Alzheimer’s disease: the possible role of retromer.

Authors:  Saeed Sadigh-Eteghad; Mohammad Sadegh Askari-Nejad; Javad Mahmoudi; Alireza Majdi
Journal:  Neurol Sci       Date:  2016-01       Impact factor: 3.307

Review 2.  Endosomal recycling reconciles the Alzheimer's disease paradox.

Authors:  Scott A Small; Gregory A Petsko
Journal:  Sci Transl Med       Date:  2020-12-02       Impact factor: 17.956

Review 3.  New approaches for studying synaptic development, function, and plasticity using Drosophila as a model system.

Authors:  C Andrew Frank; Xinnan Wang; Catherine A Collins; Avital A Rodal; Quan Yuan; Patrik Verstreken; Dion K Dickman
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

4.  Quantitative analysis of retromer complex-related genes during embryo development in the mouse.

Authors:  Sang-Je Park; Jae-Won Huh; Young-Hyun Kim; Ji-Su Kim; Bong-Seok Song; Sang-Rae Lee; Sun-Uk Kim; Heui-Soo Kim; Kazuhiko Imakawa; Kyu-Tae Chang
Journal:  Mol Cells       Date:  2011-02-22       Impact factor: 5.034

Review 5.  Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes.

Authors:  Rachel F Lane; Peter St George-Hyslop; Barbara L Hempstead; Scott A Small; Stephen M Strittmatter; Sam Gandy
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

Review 6.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

Review 7.  Pinpointing synaptic loss caused by Alzheimer's disease with fMRI.

Authors:  Adam M Brickman; Scott A Small; Adam Fleisher
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

8.  Regulation of amyloid precursor protein processing by the Beclin 1 complex.

Authors:  Philipp A Jaeger; Fiona Pickford; Chung-Huan Sun; Kurt M Lucin; Eliezer Masliah; Tony Wyss-Coray
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

9.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

Review 10.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.